Medical Source helps primary care physicians
transition to evidence based practices.
Setting up staff driven processes to supplement existing
E&M revenues will increase profitability $150,000.00 a year!
To improve your financial future, contact us today.
-
140-149
Malignant neoplasm of lip, oral cavity, and pharynx
-
150-159
Malignant neoplasm of digestive organs and peritoneum
-
160-165
Malignant neoplasm of respiratory and intrathoracic organs
-
170-175
Malignant neoplasm of bone, connective tissue, skin, and breast
-
176-176
Kaposi's sarcoma
-
179-189
Malignant neoplasm of genitourinary organs
-
190-199
Malignant neoplasm of other and unspecified sites
-
200-208
Malignant neoplasm of lymphatic and hematopoietic tissue
-
209-209
Neuroendocrine tumors
-
210-229
Benign neoplasms
-
230-234
Carcinoma in situ
-
235-238
Neoplasms of uncertain behavior
-
239-239
Neoplasms of unspecified nature
DRIVERS OF PERFORMANCE
U.S. HEALTHCARE REFORM
PRACTICE RESOURCES
